Zaloguj Zarejestruj się zadarmo

Last updated: 16 February 2024 at 5:05pm EST

Glenn Steele Net Worth



Glenn Steele PTCT stock SEC Form 4 insiders trading

Glenn has made over 10 trades of the PTC Therapeutics Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 1,017 units of PTCT stock worth $32,819 on 23 May 2018.

The largest trade he's ever made was selling 10,000 units of PTC Therapeutics Inc stock on 16 August 2016 worth over $1,148,600. On average, Glenn trades about 1,639 units every 84 days since 2009. As of 23 May 2018 he still owns at least 5,139 units of PTC Therapeutics Inc stock.

You can see the complete history of Glenn Steele stock trades at the bottom of the page.





Glenn Steele biography

Dr. Glenn D. Steele Jr. M.D. Ph.D. serves as Independent Director of the Company. Dr. Steele has served as the Chairman of xG Health Solutions, a health care redesign and optimization company affiliated with Geisinger Health System, from 2013 to 2018. From 2001 until 2015, Dr. Steele served as President and Chief Executive Officer of Geisinger Health System, an integrated health services organization in central and northeastern Pennsylvania. Dr. Steele previously served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and vice president for medical affairs at the University of Chicago, as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, president and chief executive officer of Deaconess Professional Practice Group, Boston, MA, and chairman of the department of surgery at New England Deaconess Hospital (Boston, MA). Dr. Steele serves on the board of directors of Wellcare Health Plans Inc., a NYSE-listed managed care company, and served as a director of CEPHEID, a Nasdaq-listed molecular diagnostics company, from 2011 to 2016 as well as Weis Markets Inc., a NYSE-listed supermarket chain, from 2009 to 2015.

What is the salary of Glenn Steele?

As the Independent Director of PTC Therapeutics Inc, the total compensation of Glenn Steele at PTC Therapeutics Inc is $332,105. There are 13 executives at PTC Therapeutics Inc getting paid more, with Stuart Peltz having the highest compensation of $7,759,440.



How old is Glenn Steele?

Glenn Steele is 75, he's been the Independent Director of PTC Therapeutics Inc since 2015. There are no older and 18 younger executives at PTC Therapeutics Inc.

What's Glenn Steele's mailing address?

Glenn's mailing address filed with the SEC is C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD, NJ, 07080.

Insiders trading at PTC Therapeutics Inc

Over the last 12 years, insiders at PTC Therapeutics Inc have traded over $50,602,930 worth of PTC Therapeutics Inc stock and bought 3,730,934 units worth $57,374,337 . The most active insiders traders include Suisse/ Credit, Adam Koppel oraz Bioventures Cayman Ltd Hbm. On average, PTC Therapeutics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $888,748. The most recent stock trade was executed by Pierre Gravier on 16 July 2024, trading 2,269 units of PTCT stock currently worth $77,191.



What does PTC Therapeutics Inc do?

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.



What does PTC Therapeutics Inc's logo look like?

PTC Therapeutics Inc logo

PTC Therapeutics Inc executives and stock owners

PTC Therapeutics Inc executives and other stock owners filed with the SEC include: